566 ATOR-1017, a second generation 4–1BB antibody with potential to enhance efficacy of PD-1 therapies
oleh: Karin Enell Smith, Peter Ellmark, Anneli Nilsson
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.